Artroa is developing a combination drug for arthritis. Initially, the drug will be marketed as a licensed medication for the treatment of horses. In the long term, the medication is intended for use in other animals, and eventually, clinical tests will be conducted for human medicine.
START YEAR
2020
INVESTMENT
2023
CEO
Eva Skiöldebrand
CONTACT
eva.skioldebrand@slu.se
WEBSITE
Coming soon